Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on the Metabolic Side Effects of Corticosteroid Medications.
Study Goal
The researchers aimed to determine the effects of the DASH diet, which includes low-fat dairy, on metabolic side effects in patients using corticosteroid medications.
Results Summary
The DASH diet, including low-fat dairy, significantly improved systolic and diastolic blood pressure, reduced serum total cholesterol, and lowered fasting blood glucose in corticosteroid-treated patients. No significant changes were observed in body weight or waist circumference.
Population
60 patients on corticosteroid therapy (mean age 31.1 ± 3.6 years, BMI 26.9 ± 2.6 kg/m²).
Effective Dosage
Not specified (dietary intake followed DASH guidelines).
Duration
10 weeks.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
DASH diet | no change | body weight | patients on corticosteroid therapy | no significant difference | no significant difference was observed | #1 |
DASH diet | no change | waist circumference | patients on corticosteroid therapy | no significant difference | no significant difference was observed | #2 |
DASH diet | decrease | systolic blood pressure | patients on corticosteroid therapy | - | were significantly different | #3 |
DASH diet | decrease | diastolic blood pressure | patients on corticosteroid therapy | - | were significantly different | #4 |
DASH diet | decrease | serum total cholesterol | patients on corticosteroid therapy | - | significantly decreased | #5 |
DASH diet | decrease | fasting blood glucose | patients on corticosteroid therapy | - | significantly decreased | #6 |
OBJECTIVE: We aimed to determine the effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the metabolic side effects of corticosteroid medication use. DESIGN: A randomized clinical trial was undertaken in 60 patients on corticosteroid therapy for 10 weeks. Patients were randomly assigned to a DASH or control diet. Carbohydrate, protein, and fat in both groups were 50-60%, 15-20%, 30%, respectively. DASH diet was a diet rich in fruits, vegetables, whole grains, low-fat dairy products, and low in total and saturated fat and cholesterol, refined grains, and also sweets. Fasting blood samples were collected to determine blood glucose and lipid profile. Blood pressure and anthropometric measurements were measured based on the standard guidelines. RESULTS: The mean age and body mass index (BMI) were 31.1 ± 3.6 year and 26.9 ± 2.6 kg/m(2), respectively. There were no significant differences between age and BMI in two groups at baseline. No significant difference was observed in body weight and waist circumference following the DASH diet compared to control diet. Systolic and diastolic blood pressures were significantly different following the DASH eating pattern (P = 0.04). Serum total cholesterol and fasting blood glucose significantly decreased in those following the DASH diet after adjustment for potential confounders. CONCLUSION: The DASH diet had beneficial effects on several metabolic side effects among patients using corticosteroid medications.